Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LOL! Wow! Certain quarters are VERY~VERY~VERY~WORRIED about RXMD and their news of their data-analytics subsidiary and their moves toward uplisting to NASDAQ.
If they're counting on RXMD failing, they should be worried, because RXMD is putting all the pieces in place to make its investors rich.
LOL! Wow! Certain quarters are VERY~WORRIED about RXMD's news yesterday about their data-analytics subsidiary and their moves toward uplisting to NASDAQ.
If they're counting on RXMD failing, they should be worried, because RXMD is putting all the pieces in place to make its investors rich.
LOL! Wow! Certain quarters are very worried about RXMD's news today about their data-analytics subsidiary.
If they're counting on RXMD failing, they should be worried, because RXMD is putting all the pieces in place to make its investors rich.
Certain quarters are very worried about RXMD's plans to uplist to NASDAQ.
If they're counting on RXMD failing, they should be worried, because RXMD is putting all the pieces in place to make its investors rich.
You think a company like RXMD with 500 million shares should have to raise their market cap to $2 billion before being able to uplist, as some sort of penance for issuing 500 million shares in the first place?
RS in order to uplist isn't "weak"; RS in order to prevent delisting is what's a sign of weakness. RS to uplist is just the company putting its house in order for its next stage.
As RXMD gets closer to NASDAQ, the SP will go up. After today, the SP is over 5 cents. If they went to RS today, it would only be 75:1.
Word's getting out about RXMD, and the trade volume shows that interest (and SP) is growing. I don't believe the final RS will be anywhere near 100:1.
Whatever it takes to get us to NASDAQ is fine with me. If NASDAQ says RXMD needs a $4 share price, dividing the number of shares accordingly doesn't affect the company's value one bit.
RXMD is growing, and it's ridiculous to expect a small-but-growing company to have to increase their company value to $2 billion before uplisting, just because they issued 500 million shares back in the day. In this case, a reverse-split is just putting their house in order for the new stage they're about to appear on.
As the article I linked to previously said, if a NASDAQ company has to reverse-split in order to prevent delisting, that's a whole other matter, but it simply doesn't apply here with regards to RXMD.
Yep, I'll vote YES for a reverse-split as well. The blind condemnation of RS never made any sense to me; it's a tool, like anything else. Once RXMD does RS and moves to NASDAQ, those mayflies will wither away; I suspect the Venn diagram of those naysayers and actual RXMD investors doesn't have a lot of overlap.
Certain quarters are very worried about Stockforce's great analysis of RXMD's upcoming S-1 filing.
If they're counting on RXMD failing, they should be worried, because RXMD is putting all the pieces in place to make its investors rich.
Great BUY volume today!
A lot of worry evident from certain quarters about RXMD's growth and progress towards uplisting to NASDAQ.
If they're counting on RXMD failing, they should be worried, because RXMD is putting all the pieces in place to make its investors rich.
If you find an instance of a stock being traded on a national exchange WITHOUT having filed an S-1, let me know.
Otherwise, I'm going to go by what Investopedia said on the subject...
Here's some info about uplisting to a national exchange I found interesting. The part about reverse-splits (quoted below) fits with how I figured OTC companies uplist to national exchanges.
Once again, everything I've found says simply that form S-1 is required to list on a national exchange. Yes, it is USUALLY done as part of an IPO, but how many OTC stocks ever uplist to a national exchange?
Yet again, quoting from the article about it on Investopedia (emphasis mine):
The S-1 filing is required for RXMD to uplist to a national exchange, which is one of RXMD's goals.
Furthermore, RXMD isn't even a Pink anymore. If you'll recall, RXMD's then-new leadership got the company's house in order and went from OTC-Pink(Limited) to OTC-Pink(Current), before moving up to OTCQB.
Like the move to OTCQB itself, the S-1 filing is just another step toward NASDAQ, one that will pay off handsomely for smart investors who get in now.
RXMD is working toward meeting all the necessary criteria to uplist.
At the end of the day, RXMD needs the S-1 form filed in order to uplist to NASDAQ, and no hair-splitting will change that.
RXMD or rando? Eh, I'll stick with the third-party-audited company that is expanding and on-track to uplist to NASDAQ, thanks. :)
RXMD's on track for their S-1 filing (needed for uplisting to NASDAQ), and their May numbers reported:
• Consolidated monthly gross sales across all locations totaled $3 million, representing year-over-year growth of 67% compared to May 2019
• Prescriptions filled during the month came in at 40,062, representing year-over-year growth of 41% compared to May 2019
• 340B claim processing from FQHCs increased to $1.1 million, generating roughly $127K in agency fees.
• Three new FQHCs will come online in July 2020 under dispensing and data analytics contracts
• Consolidation into 400 Ansin location now underway, set to drive savings exceeding $300K in early 2021
...and you got "failure" and "horrible" from that?
:)
Okay, I'm going to try this once more. Let me know which part of the following sentence confuses you:
From Investopedia (emphasis mine): "Any security that meets the criteria must have an S-1 filing before shares can be listed on a national exchange, such as the New York Stock Exchange."
I didn't say that an S-1 form "uplists a company", but Investopedia quite clearly states that an S-1 form is required in order for a company to be uplisted.
In this thread, you seemed to think RXMD couldn't file an S-1, first because, in your words, "an S-1 is not a form for uplisting to a new exchange".
Then, after I showed that an S-1 form absolutely IS for uplisting to a new exchange, you replied, "RXMD is not doing an IPO. They are already publicly traded."
At that point, I responded by pointing out the relevant passage from Investopedia, which says that while S-1 forms are "usually filed in anticipation of an IPO", "[a]ny security that meets the criteria must have an S-1 filing before shares can be listed on a national exchange, such as the New York Stock Exchange."
Hope that helps.
LOL! I totally believe you. Totally. Just making the board aware.
LOL! PAY~NO~ATTENTION~TO~THE~EXPANDING~COMPANY~THAT~IS~ABOUT~TO~UPLIST!
Quite the "kinky little gimmick", isn't it? LOL!
RXMD! :)
I can't wait to see your proof that the company RXMD bought "cooked the books".
So what? If that gets RXMD over the final hurdle to uplisting to a national exchange, that's great!
Or what? You expect them to wait until they're a $500 million company to uplist simply because they have 500 million shares? That's ridiculous. Far better to reduce the number of shares and move RXMD on to bigger and better things.
You're talking about two distinct conditions. To prove your argument, all you need to do is match the companies that meet both those conditions. It's really a simple data analysis.
It's your argument to prove, not mine to debunk.
Do the work: make a list of all companies that have filed 15-12Gs, and a list of all fully-reporting companies that uplisted to a major exchange, then compare the two. If you find zero matches, your argument is proven.
Otherwise... it's just wind.
I'm going to need to see some proof of your unsupported statement.
Reread my post quoting from Investopedia. It says an S-1 is "usually filed in anticipation of an IPO". That obviously doesn't apply here.
Clearly Some Of You Don't Understand what a great company RXMD is. Growing its business, expanding its locations, and soon to be traded on a national exchange.
How adorably KINKY, LOL!
The S-1 form is definitely part of the process for RXMD to uplist to a national exchange.
From Investopedia:
What is SEC Form S-1?
SEC Form S-1 is the initial registration form for new securities required by the SEC for public companies that are based in the U.S. Any security that meets the criteria must have an S-1 filing before shares can be listed on a national exchange, such as the New York Stock Exchange. Companies usually file SEC Form S-1 in anticipation of their initial public offering (IPO). Form S-1 requires companies to provide information on the planned use of capital proceeds, detail the current business model and competition and provide a brief prospectus of the planned security itself, offering price methodology and any dilution that will occur to other listed securities.
SEC Form S-1 is also known as the registration statement under the Securities Act of 1933. Additionally, the SEC requires the disclosure of any material business dealings between the company and its directors and outside counsel. Investors can view S-1 filings online to perform due diligence on new offerings prior to their issue.
Foreign issuers of securities in the U.S. do not use SEC Form S-1 but instead must submit an SEC Form F-1.
Key Takeaways
* SEC Form S-1 is an SEC registration required for U.S. companies that want to be listed on a national exchange.
* It is basically a registration statement for a company that is usually filed in connection with an initial public offering.
* Any amendments or changes that have to be made by the issuer are filed under SEC Form S-1/A.
* The issuer is responsible for any material misrepresentations or omissions.
RXMD, an expanding company with new revenue streams, "isn't real"?
LOLOLOLOLOLOLOLOLOLOLOLOLOL!
"Kinky"? What the hell is that supposed to mean?
LOLOLOLOLOLOLOLOLOLOLOLOLOLOLOL!!!
Good luck with that one.
Once RXMD uplists, all this penny nonsense will be over.
LOL! "This thing's garbage, sell me your RXMD shares cheap!"
Looking forward to hearing more about today's news on tomorrow's conference call! Tomorrow's trading should be fun. Monday's will be AMAZING!
Go RXMD!!!
DESPERATE shorts need RXMD closing under $0.09 today. They're going to be sorely disappointed as RXMD pushes a dime at close.
Shorts' losses are UNLIMITED with RXMD!
We should hit 10 cents today! Tomorrow, with the CC inevitably talking more about today's news... who knows? The sky's the limit!
Go RXMD!
RXMD is expanding and growing! The past twelve months have set the stage for what we're seeing today, and the past few years have set the stage for the past twelve months.
One quarter at a time, one goal at a time, this management team has put everything in place for RXMD to continue moving upward!
Power Hour today is going to be AMAZING!
Go RXMD!
Sky's the limit for shorts today with RXMD!!!
Go RXMD!!!